Creating Hope Reauthorization Act of 2024

Cost and committee reports

Official records Congress.gov attaches to H.R. 7384.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. McCAUL, as printed in the Congressional Record (Vol. 170, No. 30, February 15, 2024, Page H680):
  Artile I, Section 8 The single subject of this legislation is: This bill reauthorizes a Food and Drug Administration (FDA) program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases.
  Source: Congress.gov, Congressional Record February 15, 2024 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  229 characters

  Congress.gov bill record

  H.R. 7384, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/7384

  Record last updated by Congress.gov

  May 27, 2025

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  0c07de2fa17663b6336a380ae8bd3efc510bdb1172552b9c58f9808aa2c88f02

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of May 27, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 7384, last updated May 27, 2025. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.